Advocacy intelligence hub — real-time data for patient organizations
Qianfoshan Hospital
Qianfoshan Hospital
First Affiliated Hospital of Ningbo University
First Affiliated Hospital of Ningbo University
Qianfoshan Hospital
Radboud University Medical Center — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Noxafil
(posaconazole)Orphan drugMerck Sharp & Dohme LLC
Azole Antifungal [EPC]
12.1 Mechanism of Action Posaconazole is an azole antifungal agent [see Clinical Pharmacology (12.4) ] .
Cresemba
(isavuconazonium sulfate)Orphan drugAstellas Pharma Global Development Inc.
12.1 Mechanism of Action Isavuconazonium sulfate is the prodrug of isavuconazole, an azole antifungal [see Microbiology ( 12.4 )] .
Dupixent
(dupilumab)Orphan drugstandardRegeneron Pharmaceuticals, Inc.
Interleukin-4 Receptor alpha Antagonist [EPC]
12.1 Mechanism of Action Dupilumab is a human monoclonal IgG4 antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling by spec...
François Laurent, MD
University Bordeaux Hospital
Thomas S Poore, MD
University of Colorado, Denver
Julie MACEY, MD
University Hospital, Bordeaux
Roger Brüggemann, PhD
Radboud University Medical Center
Ritesh Agarwal, MD, DM
Postgraduate Institute of Medical Education and Research, Chandigarh, India
Jay K Kolls, MD, MD
University of Pittsburgh
📍 NEW ORLEANS, LA
View all Allergic bronchopulmonary aspergillosis specialists →